Sangbin Lim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.
Journal: Cancer cell international
Published: May 23, 2023
Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models.
Journal: Therapeutic advances in medical oncology
Published: November 17, 2021
Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib.
Journal: JTO clinical and research reports
Published: April 21, 2021
Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 27, 2021
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models.
Journal: Clinical & translational immunology
Published: February 17, 2021
Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768I.
Journal: Molecular cancer therapeutics
Published: February 12, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.
Journal: Cancer discovery
Published: January 31, 2020
Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
Journal: Antioxidants & redox signaling
Published: July 01, 2016
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.
Journal: Journal of medicinal chemistry
Published: November 28, 2015
Carbonyl reductase 1 is an essential regulator of skeletal muscle differentiation and regeneration.
Journal: The international journal of biochemistry & cell biology
Published: April 11, 2013
Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
Journal: BMC medicine
Published: April 05, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026